Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000290

Options or other derivatives

  • President and CEO acquired 179,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BLATT LAWRENCE · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-16 Grant or award : show line 1 in the form Stock Option (Right to Buy) +179,800 179,800 D
Loading xslF345X05/form4.xml…